$170,000 of BEIGENE USA INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to drug pricing, implementation of the Inflation Reduction Act, pharmacy benefit managers legislation."
You can find more data on corporate lobbying on Quiver Quantitative.
BGNE Insider Trading Activity
BGNE insiders have traded $BGNE stock on the open market 64 times in the past 6 months. Of those trades, 0 have been purchases and 64 have been sales.
Here’s a breakdown of recent trading of $BGNE stock by insiders over the last 6 months:
- ADVISORS, LTD. HHLR sold 17,842,500 shares for an estimated $3,568,500,000
- BROS. ADVISORS LP BAKER has made 0 purchases and 4 sales selling 1,037,017 shares for an estimated $194,200,043.
- XIAODONG WANG has made 0 purchases and 33 sales selling 131,871 shares for an estimated $24,366,190.
- JOHN OYLER (Chief Executive Officer) has made 0 purchases and 14 sales selling 16,175 shares for an estimated $3,756,092.
- XIAOBIN WU (President, COO & GM China) has made 0 purchases and 8 sales selling 10,556 shares for an estimated $2,054,291.
- LAI WANG (Global Head of R&D) sold 5,000 shares for an estimated $1,101,774
- CHAN HENRY LEE (SVP, General Counsel) has made 0 purchases and 2 sales selling 2,036 shares for an estimated $418,909.
- TITUS B. BALL (Principal Accounting Officer) sold 137 shares for an estimated $26,021
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BGNE Hedge Fund Activity
We have seen 102 institutional investors add shares of BGNE stock to their portfolio, and 112 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TEMASEK HOLDINGS (PRIVATE) LTD removed 625,595 shares (-20.8%) from their portfolio in Q3 2024, for an estimated $140,452,333
- CAPITAL INTERNATIONAL INVESTORS removed 582,684 shares (-8.3%) from their portfolio in Q3 2024, for an estimated $130,818,384
- PRICE T ROWE ASSOCIATES INC /MD/ added 427,266 shares (+18.8%) to their portfolio in Q3 2024, for an estimated $95,925,489
- VESTAL POINT CAPITAL, LP removed 350,000 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $78,578,500
- ARTAL GROUP S.A. removed 303,369 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $68,109,374
- POINT72 ASSET MANAGEMENT, L.P. added 285,784 shares (+74.9%) to their portfolio in Q3 2024, for an estimated $64,161,365
- CAPITAL INTERNATIONAL, INC./CA/ removed 230,239 shares (-26.9%) from their portfolio in Q3 2024, for an estimated $51,690,957
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
